Be game changers in global oncology
4th and 5th ASCO- GOIS International Webinars (ASCO-GOIS IW)
The 4th and 5th webinars entitled: Examples of scientific explorations for resource-saving better-value cancer drugs-systemic therapy
Invitation
Be game changers in global oncology
(True progress lies not in punishing the past and not in repeating the previous mistakes and pitfalls but in fixing the future. That makes constructive game changers).
4th and 5th ASCO- GOIS International Webinars (ASCO-GOIS IW)
Entitled: “Examples of scientific explorations for resource-saving better-value cancer drugs-systemic therapy”
Dates: The 4th Webinar will be held on May 7, 2025 at 3.00-5.00 pm London Time
Join Zoom Meeting
https://us06web.zoom.us/j/85150386879?pwd=1QjLOPQPjnzwEEI40jmTqqZzLeLPlj.1
Meeting ID: 851 5038 6879 Passcode: 062745
The 5th webinar will be held on June 18, 2025 at 3.00-5.00 pm London Time
Join Zoom Meeting
https://us06web.zoom.us/j/89741533100?pwd=bXPHaMkTkWckgwqcmxdK9WHHbsGIra.1
Meeting ID: 897 4153 3100 Passcode: 050469
To register: Click or browse www.icedoc.website or via your mobile: https://icedoc.website/cms/login/index.php then register (It is free)
ASCO: American Society of Clinical Oncology, GOIS: Global Oncology-Implementing Science Program, Global Oncology University , GO-U) , www.icedoc.website, SEMCO is The South and East Mediterranean College of Oncology
GOIS is the 1st world professional virtual program focused exclusively on presentation and stimulation of how via scientific exploration , to increase affordability of cancer care in the real world. (It is Free and accessible to all).
The ASCO- GOIS International webinars (ASCO- GOIS IW): This series will continue the brainstorming reviewing and the discussion started in the Global Oncology-Implementing Science (GOIS) program virtual program entitled: “Be game changers in Global Oncology”.
For colleagues who like to obtain certificate of different levels of “ Game changers in global Oncology”, GOIS, GO-U, We'll send guides for evaluation and we encourage colleagues for obtaining certificates on the program at the end of the series (https://www.icedoc.website & feedback to feedback@icedoc.website
· President: Prof. Robin Zon, President, ASCO 2024-2025
· Planner and Director : Prof. Ahmed Elzawawy
· Contact: feedback@icedoc.website & worldcooperation@gmail.com
For colleagues who like to obtain certificate of different levels of “ Game changers in global Oncology”, GOIS, GO-U, We'll send guides for evaluation and we encourage colleagues for obtaining certificates on the program at the end of the series (https://www.icedoc.website & feeback to feedback@icedoc.website & worldcooperation@gmail.com
===============================================================
Goals for the (ASCO - GOIS IW) Series:
· Explore the scientific and patient centered approaches to finding and validating accessible and affordable therapies for cancer care, such as real-world data, AI, preclinical models and clinical trials
· Discuss the overall impact of readily available and affordable cancer therapies for patient globally in affluent and less affluent Countries (LMICs)
Specific Goals for the 4th and 5th webinars:
· Give concrete overview and examples on scientific resource-saving and better value Systemic Cancer Therapy.
· Propose future directions for collaborative global cancer care studies and implementation.
=========================================================================
Program of the 4th ASCO-GOIS International Webinar on May 7, 2025 at 3.00-5.00 PM GMT:
· Welcome by Planner and Director: Prof. Ahmed Elzawawy
· Welcome note by the President whole series ASCO-GOIS International Webinars by Prof. Robin Zon, President, ASCO 2024-2025 https://youtu.be/0eUPIWvnejg?si=-qTFG_ItS9Yyt8xo (3’)
· Introductory notes by Prof. David Kerr “The need and importance of scientific works for better value cancer care, scientific better optimizations of doses, and revisiting concepts in trials of new drugs”. https://www.youtube.com/watch?v=Trazgpsb7Dk (6 ‘)
Soto
Outlines:
Ø Prof. Ahmed Elzawawy “Examples of scientific explorations for resource-saving better-value cancer drug systemic therapy “
Key notes: By the Chairs: Prof Ian Tannock , Prof. David Kerr, Prof. Katherine Van Loon and Prof. Enrique Soto
Ø Prof. Ian Tannock” Can Anti-Cancer Drugs be Administered in Shorter Courses or at Lower Doses to Improve Access to Effective Treatment
What evidence do we need to change practice?
Ø Prof. David Kerr, “Optimizing dose selection for cancer Medicine”
Ø Prof. Eduardo Caza“ Practical examples of current scientific explorations for resource-saving cancer care”
Ø Prof. Katherine Van Loon “The Promising role of JCO Global Oncology in increasing affordability of better value cancer care in the world via scientific approaches and studies”
Ø Prof. Enrique Soto “ ecancer and the scientific movement to increase affordability of cancer care without compromising the outcome”
o Discussion by The Distinguished Board and Panelists in Alphabetical order:
Stephan Avery, USA, Jacques Bezuidenhout, Belgium, Eduardo Cazap, Argentina, Ahmed Elzawawy, Egypt, Bishal Gyawali, Canada and Nepal, David Kerr, UK, Hussein Khaled, Egypt, L. Incrocci , Netherlands and Italy, Katherine Van Loon, USA, Abba Mallum, R. South Africa, N. Mobarek, Egypt, Twalib Ngoma, Tanzania, Wil Ngwa, USA, Aparna R. Parikh, USA, Ali Razek, USA and UEA, Karol Sikora, UK, Enrique Soto, USA, Susannah Stanway, UK, Cristina Stefan, R South Africa and Namibia, Ian Tannock, Canada, Robin Zon, ASCO, President 2024-2025
Ø Rapporteurs: Jacques Bezuidenhout and Abba Mallum.
o Then Open Discussion, Q& A . Then Conclusion and future Direction.
=================================================
President of the Series ASCO-GOIS International Webinars: Prof. Robin Zon, ASCO President, 2024-2025
Chairs of the series:
· Prof. David Kerr , Oxford University, UK , Past Chair of ASCO International Affairs Committee. Past President of ESMO, Leader of the win-win initiative and Co-founder of GO-U & GOIS https://youtu.be/PbORxWpnLXA
· Prof. Eduardo Cazap, Argentina, MD, PhD, FASCO, President & Founder of SLACOM , Co-chair RINC , Global Oncology Patron – ecancer , Past President UICC, Past Chair, ASCO International Affairs Committee, Leader of the win-win initiative and Co-founder of GOIS, GO-U
· Prof. Ian Tannock, Canada, MD, PhD, Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and University of Toronto
· Prof. Enrique Soto, USA, MD, The Editor in Chief of ecancer, Professor of Medical Oncology & Geriatric Oncology and Associate Director for global oncology, University of Colorado, USA,
==================================
Short information about the speakers:
President: Prof. Robin Zon, ASCO President, 2024-2025
Prof. Robin Zon, MD, FASCO, FACP, USA. President of ASCO term 2024-25 . Dr. Zon currently practices as Physician Emeritus at Michiana Hematology Oncology in Mishawaka, IN, where she previously served as President. She formerly served as Medical Director of Oncology Research at Memorial Hospital and National Cancer Institute Community Clinical Oncology Program Associate and then Principal investigator. https://youtu.be/0eUPIWvnejg?si=WU09k4RG0Mly3GFo
==================================
Professor David Kerr CBE MD PhD DSc FRCP FRCGP FACP FESMO FMedSci, UK : David contributes to Oxford as Professor of Cancer Medicine, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U
==================================
Prof. Eduardo L. Cazap MD, PhD, FASCO, Argentina , President & Founder -Latin-American & Caribbean Society of Medical Oncology (SLACOM) Co-Chair, Network of Latin American Cancer Institutes (RINC) .Past President - Union for International Cancer Control (UICC) , Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U
==================================
https://medbio.utoronto.ca/faculty/tannock
Prof. Ian Tannock, MD, PhD, is Emeritus Professor of Medicine and Medical Biophysics at Princess Margaret Cancer Centre and University of Toronto. His clinical expertise is in GU and breast cancer. His research investigated methods related to cancer clinical trials, and he chaired trials for men with metastatic prostate cancer that led to licensing of drugs that are used worldwide for this disease. Dr. Tannock is an editor of the Basic Science of Oncology textbook
Dr. Tannock was a member of the Board of Directors of ASCO from 2001-2004. He chaired (2018-2020) the ASCO working group that organizes International Clinical Trials Workshops. Since retiring from active practice and lab-based research in 2014, Dr Tannock teaches both locally and internationally, and authors papers relating to clinical trial methodology.
==================================
Prof. Enrique Soto Perez De Celis, MD, PhD. The Editor in Chief of ecancer, Professor of Medical Oncology & Geriatric Oncology and Associate Director for global oncology, University of Colorado , USA, He served on the Board of Directors of ASCO , he has joined the distinguished faculty of the ASCO-GOIS International Webinars
==================================
Dr. Aly Abdel Razek, M.D., FACRO , USA & UEA. American Board certified in both Pediatrics and Radiation Oncology, Chief of Radiation Oncology, Executive Director, Gulf International Cancer Center, Abu Dhabi, UEA , President , Medical Sources International, Co-authors of four textbook in Radiation Oncology. He served in National Committee of South West Oncology Group, USA. & Vice President, ICEDOC, SEMCO and Co-Chair , GOIS program, GO-U. ( & ASCO)
=================================
Professor Karol Sikora, MA, MB BChir, PhD, MD, FRCR, FRCP, FFPM, UK , Consultant Oncologist, is the Medical Director of Cancer Partners International. He was the Founding Dean and now Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London. He was seconded to be Director of the WHO Cancer Programme in 2000. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U.
==================================
Prof. Ahmed Elzawawy, MD, PhD, Founding Chair, win-win Scientific initiative & Co-founder & Chair, Board of Directors, GO-U & Global Oncology-Implementing Science Courses and program & Founding President, ICEDOC & Past President, AORTIC & Prof. Clinical Oncology, Suez Canal University & Chair. Clinical and Radiation Oncology Center , Port Said, Egypt.
==================================
Prof. Hussein Khaled, Ex. Minister of High Education , Egypt, Prof. Medical Oncology, Ex. Dean NCI , Cairo and Vice Chancellor , Cairo University , Chair , SEMCO , Co-leader, The win-win Initiative
==================================
Prof. Wilfred Ngwa, PhD, Dana-Farber/Harvard Cancer Center, University of Massachusetts Lowell, and Johns Hopkins University, USA. He is a distinguished professor of global public health, and distinguished professor of public health. He is founding Director of the Global Health Catalyst launched at the Harvard Radcliffe Institute in 2015 He currently chairs the Africa Health and Infrastructure Committee advising the USA government on Global Health. He is a co-founder (with Prof Ahmed Elzawawy and distinguished faculty) of Global Oncology University. Founder Director, GHC& Co-founder, GO-U. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, GO-U
==================================
Aparna R. Parikh, MD, FASCO, USA. Associate Professor of Medicine, Harvard Medical School , Director of the MGH Cancer Center's Global Cancer Care Program, Director of Colorectal Medical Oncology, Medical Director Center for Young Adult Colorectal Cancer, Massachusetts General Hospital Cancer Center ,Tucker Gosnell Center for Gastrointestinal Malignancies ,Termeer Center for Targeted Therapies . Dr. Parikh has a long-standing interest and background in global health and has experience in many LMICs.
==================================
Dr Susannah Stanway, is an honorary consultant medical oncologist at the Royal Marsden Hospital in the UK, specializing in breast cancer with an interest in global cancer care. She is a past president of the Oncology Section at the Royal Society of Medicine and she is one of the founders of London Global cancer week
===============================
Prof. Twalib A. Ngoma , Prof. Clinical Oncology , Research Chair Holder Muhimbili University of Health and Allied Sciences MUHAS , Dar es Salaam, Tanzania. Co-Leader, The win-win initiative and Co-Founder, Global Oncology University GO-U
==================================
Bishal Gyawali, MD, PhD is an associate professor in medical oncology and public health sciences and scientist in Queen’s University, Kingston, Canada. Dr. Gyawali’ s areas of academic interests include cancer policy, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, supportive care, cancer care disparities, and global oncology. He introduced the term “cancer groundshot” advocating for investments in implementation of proven interventions for global cancer control. He is a member of the WHO Essential Medicines List Committee for cancer drugs; ESMO-MCBS, ESMO Communications, and ESMO Public Policy committees, and ASCO-Health Equity and Outcomes Committee. He is the co-founder of the “Common Sense Oncology”
==================================
Dr. Abba Mallum is an Associate Prof of Radiation Oncology. a consultant and medical specialist at Inkosi Albert Luthuli Central Hospital in South Africa. He is actively involved in global oncology collaborations and in GOIS, GO-U
================================
Dr. Jacques Bezuidenhout , Master degree of Medicine cum laude (Radboud Universiteit Nijmegen, 2009-2011) Master of Advanced Oncology (University of Ulm, 2017-2020), ESMO Academy and examination (2019), Postgraduate diploma in Health Economics (University of Cape Town, starting February 2024). His clinical work mainly urological and gastrointestinal tumors with a particular focus on MRI-guided radiotherapy. Growing up in South Africa and studying and working in different high-income countries in Europe highlighted the enormous disparities that exist in access to oncological care. This sparked his interest in global oncology.
================================
Upcoming webinars:
2nd Series of ASCO-GOIS International Webinars , Five webinars: ” How to increase access and affordability to radiation oncology and prospects of molecular radiotherapy in combination with immunotherapy’. ( They are based on sessions 15-21 , pages 28 -35 in this file https://icedoc.website/GOIS_Program_2023-2024.pdf ) . The tentative date will start on Wednesday, September 17, 2025 at 3.00-00.5 pm GMT Time. The 5th webinar will be on Wed. June 17, 2026
================================
If you are not register yet in GOIS , then register-for free- in www.icedoc.website , then click Register, or click directly https://icedoc.website/cms/login/index.php, then fill the form and submit.
Hence, you’ll receive the zoom links to webinars and regular information about programs, courses and collaborations
================================
Acknowledgement to Mr. Doug Pyle, ASCO for collaboration with the win-win international scientific initiative since more than 2 decades & Ms. Jessica Williams and Ms. Sarah Bachmann, Global Impact , ASCO.
-We thank all the leaders and faculty of GOIS, GO-U. and to colleagues everywhere in the world.
Contact: Prof . Ahmed Elzawawy feedback@icedoc.website & worldcooperation@gmail.com
. Warm Welcome